Yasir Khan | Biology and Life Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Research Excellence Award

Yasir Khan
Aligarh Muslim University, India
Yasir Khan
Affiliation Aligarh Muslim University
Country India
Scopus ID 56673715100
Documents 12
Citations 306
h-index 8
Subject Area Biology and Life Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9277-7164

Yasir Khan is an Indian researcher affiliated with Aligarh Muslim University whose academic work spans parasitology, immunomodulation, bone biology, and translational biomedical sciences. His research activities include investigations into helminth-derived immunomodulatory proteins, inflammatory disease pathways, metabolomics, and osteogenic biology. Through interdisciplinary collaboration and peer-reviewed scientific publications, Khan has contributed to research areas associated with autoimmune disease modulation, anti-inflammatory therapeutics, and experimental bone biology.[1] His scholarly profile reflects an integration of molecular parasitology with biomedical innovation, particularly in relation to immune-mediated disorders and skeletal health.[2]

Abstract

This academic article presents a professional overview of the scientific profile and research contributions of Yasir Akhtar Khan in the fields of parasitology, immunomodulation, inflammatory disease biology, and bone research. His work has explored the therapeutic and immunological significance of helminth-derived molecules, osteogenic mechanisms, metabolomics, and anti-inflammatory pharmacological studies. The article also evaluates his publication record, citation metrics, and scholarly impact within Biology and Life Sciences. Particular emphasis is placed on his interdisciplinary investigations involving autoimmune diseases, bone metabolism, and experimental therapeutics.[3]

Keywords

  • Helminth Immunomodulation
  • Autoimmune Diseases
  • Bone Biology
  • Parasitology
  • Inflammatory Disease Research
  • Metabolomics

Introduction

Contemporary biomedical research increasingly depends on interdisciplinary approaches that connect molecular biology, immunology, pharmacology, and translational medicine. Researchers investigating parasitic immunomodulation and inflammatory regulation have contributed significantly to understanding the interaction between pathogens and host immune systems. Within this scientific context, Yasir Akhtar Khan has developed a research portfolio focused on immune modulation, skeletal biology, and inflammatory disease mechanisms.[4]

His work has incorporated laboratory-based investigations, pharmacological evaluations, and metabolomic analyses aimed at understanding disease progression and therapeutic modulation. The combination of parasitology and bone biology in his research profile demonstrates an integrative scientific methodology that addresses both mechanistic and translational biomedical questions.[5]

Research Profile

Yasir Akhtar Khan has been associated with Aligarh Muslim University since 2018 in teaching and research activities related to parasitology and zoology. Prior to this appointment, he conducted research at the Central Drug Research Institute in Lucknow, India, where his work included investigations in endocrinology and experimental bone biology.[1]

His doctoral studies at Aligarh Muslim University focused on molecular and immunoparasitology, establishing a scientific foundation for subsequent investigations into helminth-derived immunomodulatory proteins and inflammatory disease pathways. His research interests include helminth immunomodulation, autoimmune disorders, parasitology, osteogenic signaling, and inflammatory regulation.[2]

The researcher has also been associated with externally funded projects, including investigations supported by the Science and Engineering Research Board in India. These projects addressed immune response modulation and pathological regulation in rheumatoid arthritis models using Fasciola gigantica-derived proteins.[6]

Research Contributions

Among Khan’s notable scientific contributions is his work investigating the protective role of Fasciola helminth defense molecule-1 in experimental arthritis models. The study explored osteoclast inhibition and demonstrated potential implications for inflammatory bone diseases without broad systemic immune suppression.[7]

Additional contributions include studies related to osteopenia reversal, bone marrow adipogenesis, fracture healing, and osteo-angiogenic regulation in experimental models. His work on anti-hypertensive and hemorheologic drugs further examined vascular function and osteogenic effects associated with bone health in hypertensive animal models.[8]

Khan has also participated in metabolomics and phytochemical investigations involving medicinal plants such as Aegle marmelos and Commiphora madagascariensis. These studies examined antioxidant and anti-inflammatory activities using in vitro and in vivo models, contributing to the understanding of bioactive plant compounds in biomedical research.[9]

His interdisciplinary scholarship additionally includes scientific literature related to microbial nanotechnology and protozoa-mediated nanoparticle synthesis, reflecting broader engagement with emerging biomedical technologies and translational applications.[10]

Publications

  • Metabolomics and anti-inflammatory activity of Commiphora madagascariensis jacq. leaves extract using in vitro and in vivo models, Journal of Chromatography B (2024).
  • The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats: A Study of Anti-hypertensive and Hemorheologic Drugs, Calcified Tissue International (2023).
  • Metabolite Profiling, Isolation of Cyclic Polyols, Antioxidant and Anti-inflammatory Activities of Aegle Marmelos, Journal of Herbs, Spices & Medicinal Plants (2021).
  • Protozoa: As Emerging Candidates for the Synthesis of NPs, Microbial Nanotechnology: Green Synthesis and Applications (2021).
  • Fasciola helminth defense molecule‐1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response, The FASEB Journal (2020).

Research Impact

The research output of Yasir Akhtar Khan demonstrates measurable scholarly visibility through indexed publications, citation metrics, and interdisciplinary collaborations. His Scopus profile reports more than 300 citations across peer-reviewed publications with an h-index of 8, indicating sustained academic engagement within biomedical and life science disciplines.[1]

The translational orientation of his work is particularly evident in studies concerning inflammatory regulation, skeletal disease models, and therapeutic immunomodulation. Research findings associated with helminth-derived biomolecules have contributed to ongoing discussions regarding alternative approaches to inflammatory disease treatment and immune regulation.[7]

His investigations into metabolomics and phytopharmacology further support scientific efforts to identify biologically active compounds with therapeutic relevance. These interdisciplinary contributions reinforce the relevance of his research within both academic and applied biomedical contexts.[9]

Award Suitability

Yasir Akhtar Khan’s research profile aligns with the objectives of the International Forensic Scientist Awards through his sustained contributions to biomedical research, experimental therapeutics, and interdisciplinary life sciences. His scientific investigations combine immunology, parasitology, metabolomics, and bone biology in a manner that demonstrates methodological rigor and translational relevance.[3]

The diversity of his publication portfolio, externally funded research activities, and citation record indicate active participation in internationally visible scientific scholarship. His contributions to immune modulation and inflammatory disease research further illustrate scientific innovation and cross-disciplinary integration that are consistent with criteria commonly associated with research excellence recognition.[6]

Conclusion

Yasir Akhtar Khan has established a scholarly profile characterized by interdisciplinary biomedical research involving parasitology, immunomodulation, bone biology, and metabolomics. His academic contributions reflect sustained engagement with translational scientific questions and experimental disease models. Through peer-reviewed publications, funded research projects, and measurable citation impact, he has contributed to the advancement of knowledge in Biology and Life Sciences. His research activities and scientific outputs collectively support recognition within international academic and research award frameworks.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Yasir Akhtar Khan, Author ID 56673715100. Scopus.
    www.scopus.com/authid/detail.uri?authorId=56673715100
  2. ORCID. (n.d.). Yasir Akhtar Khan ORCID Profile.
    orcid.org/0000-0001-9277-7164
  3. International Forensic Scientist Awards. (n.d.). Research Excellence Award Program Information.
    forensicscientist.org
  4. Khan, Y. A. et al. (2020). Fasciola helminth defense molecule‐1 protects against experimental arthritis by inhibiting osteoclast formation and function without modulating the systemic immune response. The FASEB Journal.
    https://doi.org/10.1096/fj.201901480rr
  5. Khan, Y. A. et al. (2019). Reversal of Osteopenia in Ovariectomized Rats by Pentoxifylline. Calcified Tissue International.
    https://doi.org/10.1007/s00223-019-00567-4
  6. Science and Engineering Research Board. (2018). Modulation of systemic immune response and pathology in DBA-1 mouse model of rheumatoid arthritis by Fasciola gigantica derived immunomodulatory proteins.
  7. Khan, Y. A. et al. (2020). Experimental arthritis modulation through helminth defense molecules. The FASEB Journal.
    https://doi.org/10.1096/fj.201901480rr
  8. Khan, Y. A. et al. (2023). The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats. Calcified Tissue International.
    https://doi.org/10.1007/s00223-023-01170-4
  9. Khan, Y. A. et al. (2024). Metabolomics and anti-inflammatory activity of Commiphora madagascariensis jacq. leaves extract. Journal of Chromatography B.
    https://doi.org/10.1016/j.jchromb.2024.124214
  10. Khan, Y. A. et al. (2021). Protozoa: As Emerging Candidates for the Synthesis of NPs. Microbial Nanotechnology: Green Synthesis and Applications.
    https://doi.org/10.1007/978-981-16-1923-6_8

Qingbao Guo | Neuroscience | Outstanding Scientist Award

Published on by Forensic Scientist Awards

Prof. Qingbao Guo | Neuroscience | Outstanding Scientist Award

Xi’an No.9 Hospital | China

Prof. Qingbao Guo is a highly accomplished Associate Chief Physician in the Department of Neurosurgery at the Second Affiliated Hospital of the Air Force Medical University (formerly Tangdu Hospital), China. He specializes in cerebrovascular disorders, brain tumors, and functional neurosurgery, and is recognized for his excellence in the diagnosis and treatment of moyamoya disease and other complex neurological conditions.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  1. Extensive Clinical Experience:

    • Over 20 years of progressive clinical practice in neurosurgery, including leadership as Associate Chief Physician at a top-tier military hospital.

    • Strong surgical expertise in cerebrovascular diseases, brain tumors, and functional neurosurgery, which are critical areas in modern neurosurgical practice.

  2. Academic Qualifications & Research:

    • A recent Ph.D. in Neurosurgery (2021–2024) focused on moyamoya disease (MMD)—a rare but significant cerebrovascular disorder.

    • Earlier Master’s-level research on peripheral vascular diseases, showing continuity in vascular-focused research.

    • Mentorship under established experts (Professors Lian Duan and Yanzheng He), enhancing academic rigor.

  3. Contribution to National Defense Health System:

    • His long-term service in military medical institutions (Air Force Medical University) underscores contributions to military medicine, a high-impact field with national importance.

  4. Interdisciplinary Relevance:

    • His work bridges clinical practice and surgical innovation, especially in the surgical management of complex neurological diseases, offering translational value to both academic and applied medicine.

🎓 Education

Prof. Qingbao Guo began his academic journey with a Bachelor’s degree in Clinical Medicine from Yan’an University (1999–2004). He furthered his specialization with a Master’s degree in Surgery (2008–2011) from Southwest Medical University, under the supervision of Prof. Yanzheng He, where he focused on clinical approaches to peripheral vascular diseases. Most recently, he earned his Ph.D. in Neurosurgery (2021–2024) from the Chinese PLA Medical School, mentored by Prof. Lian Duan, with research concentrating on the pathogenesis and surgical management of moyamoya disease.

💼 Professional Experience

Prof. Qingbao Guo has an extensive and progressive professional background in neurosurgery. He is currently serving as an Associate Chief Physician at Tangdu Hospital since September 2012, where he has amassed advanced surgical experience in managing brain tumors, vascular pathologies, and functional neurosurgical disorders. Prior to this, he was an Attending Physician at the First Affiliated Hospital of Southwest Medical University (July 2011 – August 2012), where he handled numerous vascular cases. His medical career began as a Resident Physician at Shaanxi Sengong Hospital (July 2004 – August 2008).

🔬 Research Interests On Neuroscience

Prof. Qingbao Guo’s research focuses on the pathophysiology and surgical treatment of cerebrovascular diseases, particularly moyamoya disease, a rare but serious condition affecting intracranial arteries. He is also interested in neuro-oncology, vascular neurosurgery, and advancements in functional neurosurgical procedures, with a vision to bridge translational neuroscience and surgical innovation.

🏆 Awards & Nominations

Prof. Qingbao Guo has been acknowledged for his clinical excellence and academic contribution through multiple hospital-level and regional honors. He is a nominee for the [Insert Award Name Here, e.g., “Outstanding Neurosurgeon Researcher Award 2025”] in recognition of his pioneering work in moyamoya disease surgical treatment and his consistent commitment to patient-centered research and education.

📚 Publications

🔬 Genetic Associations and Polymorphisms

  1. MTHFR Polymorphism and EDAS-induced Collateral Formation

    • [DOI: 10.3171/2024.1.JNS232121]
      Highlights the genetic influence (MTHFR) on surgical angiogenesis success post-EDAS in MMD patients.

  2. RNF213 p.R4810K Variant and Unfavorable Outcomes in Pediatric EDAS

    • [DOI: 10.1155/2024/1844190]
      Strong linkage of the RNF213 mutation with poor long-term outcomes, particularly relevant in East Asian populations.

🧪 Biomarker and Multi-Omics Studies

  1. Proteomic & Metabolomic Profiles in Pediatric MMD

    • [DOI: 10.2147/JIR.S471538]
      Identifies core disrupted pathways, potentially pointing toward new diagnostic or therapeutic targets.

  2. Complement C3 Expression & Postoperative Vasculopathy

    • [DOI: 10.2147/JIR.S451538]
      Suggests inflammatory markers like C3 as predictors of vascular changes post-intervention.

🧠 Neuroimaging and Risk Stratification

  1. MRI Vessel Wall Enhancement and MMD Outcomes

    • [DOI: 10.1007/S00330-023-10535-0]
      High-resolution MRI features were linked to clinical risk, potentially informing preoperative planning.

  2. Nomograms for Predicting Rebleeding and Outcomes

    • [DOI: 10.3171/2024.2.JNS232744]
      Well-validated clinical tools that integrate genetics and clinical features for long-term prognosis.

🧬 Pathophysiology and Comorbid Disease Connections

  1. Transcriptomics in MMD and SLE Crosstalk

    • [DOI: 10.3389/FIMMU.2024.1456392]
      A novel systems biology approach to uncover common pathways between MMD and autoimmune diseases like SLE.

  2. ZEB2 and Brain Microvascular Dysfunction Post-ICH

    • [DOI: 10.1080/15384101.2021.1959702]
      Delves into molecular mechanisms of endothelial dysfunction, bridging stroke and hemorrhage pathology.

📉 Risk Factors in Pediatric and Elderly Cohorts

  1. Preoperative Infarction & Pediatric Risk Factors

    • [DOI: 10.1007/S12975-023-01167-Z]
      Targeted focus on predictive markers in vulnerable pediatric populations.

  2. Outcomes in Elderly Post-Conservative vs. EDAS Treatment

  • [DOI: 10.3171/2023.7.JNS231060]
    Offers insights into age-specific management strategies and long-term care plans.

🔚 Conclusion

Prof. Qingbao Guo stands out as a dedicated neurosurgeon, educator, and researcher, committed to transforming patient outcomes through clinical expertise and scientific inquiry. His extensive training, hands-on experience, and impactful research make him a compelling candidate for any award celebrating excellence in medical and surgical innovation.

Chunxiao Wu | Neuroscience | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Chunxiao Wu | Neuroscience | Best Researcher Award

Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine | China

Dr. Chunxiao Wu (吴春晓) is a dedicated neuroscientist and clinician with a robust background in traditional Chinese medicine and modern neurological treatment. Currently serving as an Associate Professor at Guangzhou University of Chinese Medicine and a Neurology Doctor at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, she is passionate about merging acupuncture-based therapies with scientific rigor to address complex neurological disorders like stroke and Parkinson’s disease. Her work is grounded in both clinical excellence and pioneering research.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Academic Background and Career Progression

    • Dr. Wu has demonstrated consistent academic growth—from a Bachelor’s in Traditional Chinese Medicine to a PhD in Acupuncture, and now holds a position as Associate Professor.

    • Her dual role as a practicing Neurology Doctor and academic gives her research practical relevance and clinical depth.

  • Specialized and Impactful Research Area

    • Her focus on electroacupuncture for ischemic stroke and neurodegenerative disorders (e.g., Parkinson’s Disease) is both niche and highly relevant in today’s integrative medical approaches.

    • Contributions to identifying mechanisms like the NCOA4-FTH1 signaling pathway in ferroptosis add originality and depth.

  • Consistent and High-Quality Publications

    • Over 13 SCI-indexed publications, many in Q1/Q2 journals like Journal of Affective Disorders and Frontiers in Aging Neuroscience.

    • Her studies combine traditional Chinese techniques with modern bioinformatics, clinical trials, and neurochemical investigations, which enhances their scientific value.

  • Strong Research Funding Track Record

    • Principal investigator of two major national-level funded projects (NSFC and China Postdoctoral Foundation).

    • Participation in four additional NSFC projects, showing sustained involvement in collaborative and competitive research.

🎓 Education

Dr. Wu’s academic journey is marked by her deep commitment to the healing arts and medical science. She earned her Bachelor’s degree in Traditional Chinese Medicine (2009–2014) and Master’s in Acupuncture (2014–2017) from Southern Medical University. Her thirst for innovation led her to pursue a PhD in Acupuncture from Guangzhou University of Chinese Medicine (2017–2020), where she specialized in the neurological mechanisms of acupuncture therapy.

🧪 Experience

With over a decade of experience in clinical practice and scientific research, Dr. Wu has consistently advanced in her career. She began as a Postdoctoral Researcher (2020–2022) at Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, delving into electroacupuncture’s effects on ischemic stroke. Since 2022, she has been serving as a Neurology Doctor at the same hospital, and in 2023, she was appointed Associate Professor at Guangzhou University of Chinese Medicine.

🔬 Research Interests On Neuroscience

Dr. Wu’s research sits at the intersection of electroacupuncture, neurodegeneration, ischemic stroke, and ferroptosis, with a focus on molecular mechanisms such as the NCOA4-FTH1 signaling pathway and super-enhancer regulation. She applies bioinformatics and mixed-treatment comparison analyses to optimize non-pharmacological therapies for Parkinson’s disease and stroke rehabilitation.

🏆 Awards

In recognition of her significant contributions to acupuncture science and neurological rehabilitation, Dr. Wu has received:

  • 🥈 Second Prize – Science and Technology Progress Award, Chinese Society of Ethnographic Medicine

  • 🥈 Second Prize – Science and Technology Award, Guangdong Acupuncture Society

📚 Publications

Dr. Wu is a prolific author with numerous peer-reviewed publications. Her work has been widely cited in the field of integrative neurology:

  • Investigation of Ferroptosis Mechanisms in Ischemic Stroke Treated with Electroacupuncture: Focusing on the NCOA4-FTH1 Signaling Pathway​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Hong Guo, Xiang He, Yujie Lin, Li Li, Ling Feng, Qian Li, Chunzhi Tang​

    • Publication Year: 2025​

  • Bioinformatics Analysis of Electroacupuncture Treatment for Ischemic Stroke: Exploring Transcriptional Regulatory Mechanisms Mediated by Super-enhancers​

    • Authors: Chunxiao Wu, Qian Wang, Zhen Xu, Cheng Deng, Chunzhi Tang​

    • Publication Year: 2025​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Depression Risk in Patients with Stroke​

    • Authors: Chunxiao Wu, Shuang Zhu, Qian Wang, Yujie Xu, Xia Mo, Wei Xu, Zhen Xu​

    • Publication Year: 2024​

  • Development, Validation, and Visualization of a Novel Nomogram to Predict Stroke Risk in Patients​

    • Authors: Chunxiao Wu, Zhen Xu, Qian Wang, Shuang Zhu, Min Li, Chunzhi Tang​

    • Publication Year: 2023​

  • Moxibustion Treatment for Parkinson’s Disease: Study Protocol for a Randomized Controlled Trial​

    • Authors: Chunxiao Wu, Lijun Zhao, Yajing Guo, Xue Hao, Yufei Fan, Peng Wu, Jian Han, Qian Li, Xue Wang, Qian Wang, Xia Luo, Ming Zhu​

    • Publication Year: 2023​

  • The Comparative Efficacy of Non-ergot Dopamine Agonist and Potential Risk Factors for Motor Complications and Side Effects from NEDA Use in Early Parkinson’s Disease: Evidence from Clinical Trials​

    • Authors: Chunxiao Wu, Hong Guo, Yujie Xu, Li Li, Xia Li, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2022​

  • Effects of Aerobic Exercise and Mind-Body Exercise in Parkinson’s Disease: A Mixed-Treatment Comparison Analysis​

    • Authors: Chunxiao Wu, Yujie Xu, Hong Guo, Chunzhi Tang, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Integrated Bioinformatics Analysis of Potential mRNA and miRNA Regulatory Networks in Mice with Ischemic Stroke Treated by Electroacupuncture​

    • Authors: Chunxiao Wu, Lijun Zhao, Xia Li, Yujie Xu, Hong Guo, Zhen Huang, Qian Wang, Hong Liu, Dongsheng Chen, Ming Zhu​

    • Publication Year: 2021​

  • Reply to: Qigong as a Promising Mind-Body Exercise for Cognitive Functioning​

    • Authors: Chunxiao Wu, Chunzhi Tang​

    • Publication Year: 2019​

  • Effects of Mind-Body Exercises on Cognitive Function in Older Adults: A Meta-Analysis​

    • Authors: Chunxiao Wu, Qiang Yi, Xia Zheng, Shoubao Cui, Bing Chen, Lijuan Lu, Chunzhi Tang

    • Publication Year: 2019

🎯 Conclusion

Dr. Chunxiao Wu is a shining example of integrative medical excellence, combining traditional acupuncture techniques with modern neurological insights. Her passion for research, commitment to patient care, and remarkable academic output mark her as an exceptional candidate for any prestigious research award. Her future continues to hold promise as she advances the science of mind-body medicine with impactful clinical research.

Tiziana Casoli | Neuroscience | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Tiziana Casoli | Neuroscience | Best Researcher Award

Senior Researcher | IRCCS INRCA | Italy

Dr. Tiziana Casoli is a Senior Researcher at IRCCS INRCA, specializing in Applied Genetics. Since 1992, she has been actively engaged in research at the Center for Neurobiology of Aging in Ancona, Italy. Her work focuses on identifying and evaluating physiological and pathological biomarkers of the aging nervous system. She has contributed to over 100 indexed publications and participated in numerous research projects as both Principal Investigator and afferent researcher. Casoli is also a proud member of the Italian Society of Geriatrics and Gerontology (SIGG) and the European Platform of Women Scientists (EPWS).

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Research Experience: Over three decades of dedicated research in neurobiology, focusing on aging, Alzheimer’s, and Parkinson’s disease.
  • Notable Contributions: Significant contributions to understanding synaptic plasticity, mitochondrial dysfunction, and the identification of biomarkers in neurodegenerative diseases.
  • Publications and Citation Impact: 104 indexed papers and a citation index of 25, demonstrating influence in the field.
  • Leadership in Research Projects: Involvement in several high-impact projects as Principal Investigator (PI) and team member.
  • Professional Recognition: Active member of SIGG and EPWS, reflecting engagement in scholarly communities.

Education 🎓

  • Specialization in Applied Genetics, University of Bologna, Italy.

Experience 💼

  • Senior Researcher, IRCCS INRCA, Center for Neurobiology of Aging, Ancona, Italy (1992 – Present).
  • Principal Investigator and collaborator in various public and private research projects.

Research Interests On Neuroscience🔬

  • Neurobiology of Aging
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Biomarkers
  • Mitochondria

Awards 🏆

  • Member of the Italian Society of Geriatrics and Gerontology (SIGG).
  • Member of the European Platform of Women Scientists (EPWS).

Publications 📄

  1. Title: Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery

    • Authors: Giovanni Lai, Marco Malavolta, Serena Marcozzi, Giorgia Bigossi, Maria Elisa Giuliani, Tiziana Casoli, Marta Balietti
    • Year: 2024

  2. Title: Analysis of mitochondrial DNA allelic changes in Parkinson’s disease: a preliminary study

    • Authors: Tiziana Casoli, Rosamaria Lisa, Paolo Fabbietti, Fiorenzo Conti
    • Year: 2020

  3. Title: Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease

    • Authors: Tiziana Casoli, Susy Paolini, Paolo Fabbietti, Patrizia Fattoretti, Lucia Paciaroni, Katia Fabi, Beatrice Gobbi, Roberta Galeazzi, Roberto Rossi, Fabrizia Lattanzio et al.
    • Year: 2019

  4. Title: My Mind Project: the effects of cognitive training for elderly—the study protocol of a prospective randomized intervention study

    • Authors: Giuli, C.; Fattoretti, P.; Gagliardi, C.; Mocchegiani, E.; Venarucci, D.; Balietti, M.; Casoli, T.; Costarelli, L.; Giacconi, R.; Malavolta, M. et al.
    • Year: 2016

  5. Title: The effect of astaxanthin on the aging rat brain: Gender-related differences in modulating inflammation

    • Authors: Balietti, M.; Giannubilo, S.R.; Giorgetti, B.; Solazzi, M.; Turi, A.; Casoli, T.; Ciavattini, A.; Fattoretti, P.
    • Year: 2016

  6. Title: Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration

    • Authors: Casoli, T.; Spazzafumo, L.; Di Stefano, G.; Conti, F.
    • Year: 2015

  7. Title: Effect of cognitive training on the expression of brain-derived neurotrophic factor in lymphocytes of mild cognitive impairment patients

    • Authors: Casoli, T.; Giuli, C.; Balietti, M.; Giorgetti, B.; Solazzi, M.; Fattoretti, P.
    • Year: 2014

  8. Title: One-month strawberry-rich anthocyanin supplementation ameliorates cardiovascular risk, oxidative stress markers and platelet activation in humans

    • Authors: Alvarez-Suarez, J.M.; Giampieri, F.; Tulipani, S.; Casoli, T.; Di Stefano, G.; González-Paramás, A.M.; Santos-Buelga, C.; Busco, F.; Quiles, J.L.; Cordero, M.D. et al.
    • Year: 2014

  9. Title: Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer’s disease

    • Authors: Balietti, M.; Giorgetti, B.; Casoli, T.; Solazzi, M.; Tamagnini, F.; Burattini, C.; Aicardi, G.; Fattoretti, P.
    • Year: 2013

  10. Title: Platelets in Alzheimer’s disease-associated cellular senescence and inflammation

  • Authors: Casoli, T.; Balietti, M.; Giorgetti, B.; Solazzi, M.; Scarpino, O.; Fattoretti, P.
  • Year: 2013
  1. Title: Dynamin binding protein gene expression and memory performance in aged rats
  • Authors: Casoli, T.; Di Stefano, G.; Fattoretti, P.; Giorgetti, B.; Balietti, M.; Lattanzio, F.; Aicardi, G.; Platano, D.
  • Year: 2012

Conclusion 📊

Tiziana Casoli’s career is marked by a deep commitment to understanding the complexities of aging and neurodegenerative diseases. Her contributions to biomarker identification and mitochondrial research have significantly advanced knowledge in the field, while her involvement in numerous high-impact projects showcases her dedication to improving the lives of aging populations. As an active member of SIGG and EPWS, she continues to inspire and collaborate with scientists worldwide.

Haotai Xie | Medicine | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Haotai Xie | Medicine | Best Researcher Award

Peking University First Hospital | China

Dr. Haotai Xie is a dedicated clinician and researcher at Peking University First Hospital, specializing in cardiovascular diseases and bioinformatics. With a passion for advancing precision cardiology, Dr. Xie integrates computational approaches into clinical practice, enhancing diagnostic accuracy and therapeutic strategies. His work spans biomarker discovery, algorithm development, and non-invasive myocardial ischemia evaluation. Dr. Xie has authored seven first-author SCI papers in high-impact journals, contributing significantly to cardiovascular medicine and epigenetics.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Academic Productivity: Published seven first-author SCI papers in prestigious journals like Nucleic Acids Research, Briefings in Bioinformatics, and JAHA, accumulating a total impact factor exceeding 40.
  • Innovative Research: Co-developed PhaSepDB and MloDisDB, which have become cornerstone resources in phase separation research, cited in over 50 studies.
  • Interdisciplinary Expertise: Bridges cardiovascular medicine and bioinformatics, applying computational methods to improve diagnostic tools and biomarker discovery, enhancing precision cardiology.
  • Significant Contributions: Pioneered the characterization of cardiovascular phenotypes in Kleefstra syndrome, leading to evidence-based screening protocols, with direct implications for clinical guidelines and rare disease management.
  • Research Impact: Work has advanced the understanding of cardiovascular epigenetics and contributed to earlier diagnosis and more personalized treatment strategies.

🎓 Education

  • Doctorate in Clinical Medicine, Peking University First Hospital, China.

💼 Experience

  • Doctor, Peking University First Hospital.
  • Lead researcher in interdisciplinary projects bridging computational biology and cardiovascular medicine.
  • Co-developed PhaSepDB and MloDisDB, pivotal resources for phase separation research.

🔬 Research Interests On Medicine

  • Cardiovascular Medicine
  • Bioinformatics
  • Precision Cardiology
  • Biomarker Discovery
  • AI-driven Diagnostic Tools

🏆 Awards

  • Recognized for sustained academic productivity and innovation in cardiovascular research.

📓 Publications

  • “Association between urinary sodium excretion and all-cause mortality: a cohort study in a Chinese community-based population”

    • Year: 2025
    • Authors: Haotai Xie, Xinyan Wen, Fangfang Fan, Jia Jia, Yong Huo, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (published recently)

  • “Highlighting cardiovascular manifestations of Kleefstra syndrome: literature review and clinical insights”

    • Year: 2025
    • Authors: Haotai Xie, Pengkang He, Qinhui Sheng, Wei Ma, Yanjun Gong, Yan Zhang, Lin Qiu
    • Citations: Not available yet (published recently)

  • “Rethinking the Functional SYNTAX Score Threshold”

    • Year: 2024
    • Authors: Haotai Xie
    • Citations: Not available yet (upcoming publication)

  • “Research Progress and Clinical Value of Subendocardial Viability Ratio”

    • Year: 2024
    • Authors: Haotai Xie, Lan Gao, Fangfang Fan, Yanjun Gong, Yan Zhang
    • Citations: Not available yet (recent publication)

  • “PhaSepDB in 2022: annotating phase separation-related proteins with droplet states, co-phase separation partners and other experimental information”

    • Year: 2023
    • Authors: Chao Hou, Xinxin Wang, Haotai Xie, Taoyu Chen, Peiyu Zhu, Xiaofeng Xu, Kaiqiang You, Tingting Li
    • Citations: Not specified

  • “Application of B-Type Natriuretic Peptide in Neonatal Diseases”

    • Year: 2021
    • Authors: Haotai Xie, Yixuan Huo, Qinzheng Chen, Xinlin Hou
    • Citations: Not specified

  • “MloDisDB: a manually curated database of the relations between membraneless organelles and diseases”

    • Year: 2021
    • Authors: Chao Hou, Haotai Xie, Yang Fu, Yao Ma, Tingting Li
    • Citations: Not specified

🔔 Conclusion

Dr. Haotai Xie exemplifies the fusion of clinical expertise and computational innovation, driving advancements in cardiovascular medicine. His research has not only deepened the understanding of cardiovascular diseases but also paved the way for precision cardiology. With a robust publication record and interdisciplinary approach, Dr. Xie continues to shape the future of cardiovascular health management through groundbreaking discoveries and technological integration.

Silvia Di Bonaventura | Neuroscience | Women Researcher Award

Published on by Forensic Scientist Awards

Ms. Silvia Di Bonaventura | Neuroscience | Women Researcher Award

Audiologist | University College London Hospitals NHS Foundation Trust | United Kingdom

Ms. Silvia, A dedicated Clinical and Research Audiologist at University College London (UCL) with extensive experience in audiology, hearing loss management, and auditory processing disorders. With a strong academic background and significant contributions to research, this professional has played a crucial role in national health initiatives and audiological advancements.

Profile👤

ORCID

Strengths for the Awards✨

  • Academic Excellence 🎓

    • Holds a Master of Science in Advanced Audiology (with Merit) from University College London (UCL), one of the world’s top institutions.
    • Additional Master’s degree in Autism Spectrum Disorders (with Distinction).
    • Bachelor’s degree in Audiology with First Class Honours from University of Padua.

  • Significant Research Contributions 🔬

    • Key researcher in the SeaSHeL study, the largest UK cohort study on sudden sensorineural hearing loss, involving over 100 NHS hospitals.
    • Published work in BMJ Open and other platforms, contributing to the advancement of clinical audiology research.
    • Involvement in research and clinical guidelines development through the British Society of Audiology (BSA) and National Institute for Health and Care Excellence (NICE).

  • Extensive Professional Experience in Audiology & Research 👩‍⚕️

    • Senior Audiologist at UCL Hospitals NHS Foundation Trust, specializing in pediatric and advanced audiological assessments.
    • Expertise in Auditory Processing Disorders (APD), vestibular testing, and hearing aid rehabilitation.
    • Former Adjunct Professor at the University of Pisa, teaching audiological testing and hearing aid fitting.

Education 🎓

  • Master of Science in Advanced Audiology (2020-2022) – University College London (UK)
    • Obtained with Merit
    • Thesis: “The impact of idiopathic sudden sensorineural hearing loss on patients’ quality of life”
  • Master in Autism Spectrum Disorders and Communication Disorders (2020) – University “Niccolò Cusano” (Italy)
    • Obtained with Distinction
    • Thesis: “Autism and hearing loss: management of two contrasting case studies”
  • Bachelor of Science in Audiology (2014-2017) – University of Padua (Italy)
    • Obtained with First Class Honours
    • Thesis: “Evaluating aided hearing performance and functional gain in case studies: a comparison between Italy and Spain”

Experience 🌍

  • Senior Audiologist (2021-Present) – Royal National ENT and Eastman Dental Hospital, University College London Hospitals NHS Foundation Trust
    • Performing advanced audiological assessments in pediatric patients
    • Developing clinical protocols and monitoring adherence to best practices
    • Diagnosing and managing Auditory Processing Disorders (APD)
    • Leading pediatric aural rehabilitation with hearing aids and BAHA devices
  • Researcher & Member of the Central Academic Team for the SeaSHeL Study (2020-Present) – National Institute for Health Research (NIHR), London, UK
    • Coordinating the largest UK cohort study on sudden sensorineural hearing loss
    • Managing research across over 100 NHS hospitals
    • Website: SeaSHeL Study
  • Adjunct Professor (2023) – University of Pisa (Italy)
    • Teaching modules on audiometry, audiological tests, and hearing aid optimization
  • Clinical Roles in Audiology (2017-Present)
    • Paediatric Audiologist – Barts Health NHS Trust (2020-2021)
    • Audiologist – James Paget University Hospitals NHS Foundation Trust (2019)
    • Clinical Placement – Ospedale Civile “Santo Spirito,” Pescara & Treviso Regional Hospitals (2015-2016)

Research Interests On Neuroscience

  • Auditory Processing Disorders (APD) and its clinical management
  • Hearing loss and rehabilitation strategies in pediatric populations
  • Sudden sensorineural hearing loss and its impact on quality of life
  • Integration of audiology within autism spectrum disorder care

Awards 🏆

  • Erasmus+ Traineeship Winner (2017) – Funded internship in Madrid, Spain, working across five Amplifon hearing centers
  • Professional Certifications:
    • Certified Ear Microsuction Specialist (2022) – Clear Earwax, London, UK
    • Multiple membership certifications in audiology societies

Publications 📚

  • “The impact of idiopathic sudden sensorineural hearing loss on patients’ quality of life” (2022) – Published in BMJ Open
  • “Evaluating aided hearing performance and functional gain in case studies: a comparison between Italy and Spain” (2017) – Published in Journal of Audiological Research

Conclusion 🎯

A passionate audiology professional committed to research, clinical excellence, and improving patient outcomes. With a strong foundation in education and an active role in leading audiology initiatives, this expert continues to drive innovation in hearing healthcare.

Chengqun Wei | Neuroscience | Best Researcher Award

Published on by Forensic Scientist Awards

Mr. Chengqun Wei | Neuroscience | Best Researcher Award

Associate Chief Physician | Huaian Hospital of Huaian city (Huaian Cancer Hospital) | China

Dr. Chengqun Wei is the Director of the Neurology Department and an Associate Senior Physician at Huaian Hospital of Huaian City. With a medical doctorate and a specialization in neurology, he has accumulated extensive expertise in geriatric neurology. Since beginning his medical career in 2012, Dr. Wei has dedicated over seven years to the treatment of acute cerebrovascular diseases, neurological infections, and demyelinating disorders. His vast clinical experience also includes managing elderly patients with comorbidities such as hypertension, diabetes, and cardiovascular diseases.

Profile👤

Scopus

Strengths for the Awards✨

✅ Extensive Medical Expertise: With a Ph.D. in Neurology and over a decade of clinical experience, Dr. Wei has demonstrated profound knowledge in geriatric neurology, cerebrovascular diseases, and neurological infections. His ability to manage complex neurological conditions in elderly patients is highly commendable.

✅ Research Contributions: Dr. Wei has authored 7 SCI-indexed publications, indicating a strong research output. Additionally, his involvement in multiple provincial-level research projects as a principal investigator or key participant highlights his active role in advancing medical knowledge.

✅ Technical Proficiency: His expertise in network pharmacology, bioinformatics analysis, and web data mining showcases his ability to integrate computational tools with medical research, a valuable asset in modern biomedical sciences.

✅ Leadership & Experience: Holding senior positions such as Associate Chief Physician and Director of Neurology, Dr. Wei has both clinical and research leadership experience, reinforcing his credentials as a top researcher.

🎓 Education

  • 🎓 2004.09-2009.06 – Xinxiang Medical University – Clinical Medicine (BD)
  • 🎓 2009.09-2012.06 – Harbin Medical University – Neurology (MD)
  • 🎓 2020.09-2023.06 – Harbin Medical University – Neurology (PhD)

💼 Experience

  • 2012.07-2015.05 – Resident Physician, Heilongjiang Provincial Hospital
  • 2015.05-2021.08 – Attending Physician, Heilongjiang Provincial Hospital
  • 2021.09-2024.03 – Associate Chief Physician, Heilongjiang Provincial Hospital
  • 2024.03-Present – Associate Chief Physician, Huaian Hospital of Huaian City

🔬 Research Interests On Neuroscience

Dr. Wei’s research focuses on network pharmacology, bioinformatics analysis, and web data mining for scientific research. His work contributes to advancements in understanding neurological diseases, particularly in geriatric populations. He is proficient in analyzing large-scale medical data and has authored multiple research papers in high-impact journals.

🏆 Awards

  • 🌟 Principal investigator or key participant in multiple provincial-level research projects.
  • 🌟 Recognized for excellence in neurology research and contributions to geriatric neurological care.

📚 Publications

  • Title: Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
  • Authors: Quan P., Li X., Si Y., Yang F., Yao L., and others
  • Publication Year: 2024
  • Journal: Cell Communication and Signaling
  • Citations: 4

🔚 Conclusion

Dr. Chengqun Wei is a highly skilled neurologist with a strong academic background and clinical expertise in geriatric neurology. His contributions to research, particularly in bioinformatics and pharmacology, have positioned him as a key figure in neurological studies. His dedication to patient care and medical advancements continues to make a significant impact in the field of neurology.

loannis Mitsopoulos | Biological Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Mr. loannis Mitsopoulos | Biological Sciences | Best Researcher Award

PhD Student | University Of Thessaly | Greece

Ioannis Mitsopoulos, a researcher and Ph.D. candidate, is dedicated to advancing sustainable aquaculture. His work in fish and plant nutrition, focused on aquaponic systems, emphasizes a multitrophic approach to environmental balance. Ioannis has a diverse background that combines hands-on experience, interdisciplinary collaboration, and innovative research contributions in the field of agriculture and aquaculture.

Profile

Orcid

Strenghts for the Awards

  • Educational Background and Specialized Knowledge: Mr. Mitsopoulos has a solid educational foundation with an Integrated Master’s Degree in Agriculture, Fisheries, and Aquatic Environment, and is actively working on a Ph.D. focusing on aquaponics, a sustainable and innovative field. This specialized knowledge, along with participation in a Master’s program in Sustainable Fisheries and Aquaculture, positions him as a subject-matter expert in sustainable aquaculture practices.
  • Research Experience: His experience includes active involvement in research projects like “FutureAqua” and projects focused on improving the nutritional value of forage legumes for Mediterranean aquaculture species. He also contributes to critical conservation and environmental sustainability initiatives, such as monitoring fish species’ conservation status. This breadth of applied research highlights his ability to work on diverse and impactful studies.
  • Publications and Conferences: Mr. Mitsopoulos has presented his findings at multiple high-profile conferences (e.g., AQUA2018, Aquaculture Europe 2019), showing his work is recognized at international levels. His peer-reviewed publications further demonstrate the rigor and relevance of his research, especially in journals like PeerJ and MDPI. This consistent dissemination of his work to the scientific community is a strong indicator of his commitment to advancing his field.
  • Technical Skills and Certifications: Additional certifications such as the Tilapia, Shrimp, and Carp Welfare Indicators indicate his dedication to understanding animal welfare in aquaculture. This, along with technical workshops in aquaculture and environmental tolerance, shows his commitment to continuous professional development.
  • Extracurricular Involvement: His engagement in workshops, conferences, and technical seminars related to aquaculture and marine biology adds another dimension to his experience, showing a proactive approach to staying updated with current trends and methodologies in his field.

Education 🎓

Ioannis holds an Integrated Master’s Degree from the University of Thessaly, specializing in Agriculture, Fisheries, and Aquatic Environment. Currently, he is pursuing a Ph.D. in fish physiology and plant nutrition within aquaponic systems at the same institution. In 2023, he joined the University of Patras for a Master’s program in Sustainable Fisheries and Aquaculture, furthering his commitment to eco-friendly and resilient aquaculture practices.

Experience 💼

Ioannis brings a wealth of experience from internships and research projects. His hands-on work includes monitoring drinking water quality, studying marine mammal biology, and participating in numerous research initiatives. These projects have ranged from improving nutritional value in Mediterranean species to evaluating fish conservation efforts, reflecting his dedication to advancing both scientific knowledge and practical applications in aquaculture.

Research Interests 🔬

Ioannis is passionate about sustainable aquaculture, focusing on fish and plant nutrition within aquaponic systems. His interests encompass the integration of aquatic and terrestrial ecosystems, aiming to foster resilience and reduce environmental impact. He is particularly interested in multitrophic systems that enhance resource efficiency by combining species in ways that mimic natural ecosystems.

Awards and Certifications 🏆

Ioannis has been recognized for his accomplishments, including certifications in advanced scuba diving and Taekwondo. His achievements also include professional training in fish welfare indicators for tilapia, shrimp, and carp. Through workshops and seminars, he has expanded his expertise in aquaculture innovations and environmental management.

Publications 📚

Ioannis has contributed to several prestigious conferences and journals. Here are selected publications:

  • Vlahos, N., Devetzoglou, K., Mitsopoulos, I., et al. (2018). The effect of fish meal replacement with insect meal on growth performance and survival rate of zebrafish (Danio rerio). AQUA2018, Montpellier, France.
  • Mitsopoulos, I., Tzokas E., Anastasopoulos, E., et al. (2023). Starvation and re-feeding of European seabass (Dicentrarchus labrax) and Baltic prawn (Palaemon adspersus) co-cultured with glasswort (Salicornia europaea) in a polyculture aquaponic system. HydroMedit 2023, Mytilene, Greece.
  • Mitsopoulos I, Kontou IG, Babouklis K, et al. (2024). Starvation and re-feeding of Gilthead seabream (Sparus aurata) and European seabass (Dicentrarchus labrax) co-cultured with glasswort (Salicornia europaea) in a polyculture aquaponic system. PeerJ, 12

Conclusion 🌍

Through his innovative research and practical experience, Ioannis Mitsopoulos is contributing to the future of sustainable aquaculture. His work in multitrophic systems and aquaponics showcases his commitment to environmental stewardship and the pursuit of knowledge that benefits both ecosystems and human needs.